Laurus Labs Limited, commonly referred to as Laurus Labs, is a prominent player in the pharmaceutical industry, headquartered in Hyderabad, India. Founded in 2005, the company has established itself as a leader in the development and manufacturing of active pharmaceutical ingredients (APIs), generic formulations, and contract research services. With a strong focus on high-quality production, Laurus Labs offers a diverse portfolio that includes antiretroviral, oncology, and cardiovascular products, setting itself apart through its commitment to innovation and regulatory compliance. The company has achieved significant milestones, including multiple approvals from global regulatory authorities, which solidify its market position. Recognised for its robust research and development capabilities, Laurus Labs continues to expand its operational footprint across various regions, contributing to its reputation as a trusted partner in the pharmaceutical sector.
How does Laurus Labs's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Laurus Labs's score of 29 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2025, Laurus Labs reported significant carbon emissions, totalling approximately 315,457,000 kg CO2e for Scope 1 and about 181,901,000 kg CO2e for Scope 2 emissions in India. Additionally, their global emissions for the same year included 315,457,000 kg CO2e for Scope 1 and 181,901,000 kg CO2e for Scope 2. The company has not disclosed any Scope 3 emissions data for its global operations. For the previous year, 2024, Laurus Labs recorded similar emissions, with Scope 1 emissions at approximately 321,270,000 kg CO2e and Scope 2 emissions at about 176,679,000 kg CO2e in India. The Scope 3 emissions for 2024 were reported at approximately 87,212,000 kg CO2e. Laurus Labs has committed to near-term climate targets, although it has not set a net-zero target. The company is actively working within the pharmaceuticals, biotechnology, and life sciences sector to enhance its sustainability practices. Their emissions data is self-reported and not cascaded from any parent organisation, ensuring that the figures reflect their direct operational impact. Overall, Laurus Labs is focused on reducing its carbon footprint while maintaining transparency in its emissions reporting, aligning with industry standards for climate accountability.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Scope 1 | 61,436,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 205,680,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 00,000,000 | 00,000,000 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Laurus Labs has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Laurus Labs's sustainability data and climate commitments